Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Rupintrivir
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Rupintrivir |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C31H39FN4O7 |
Molar mass | 598.7 g·mol−1 |
3D model (JSmol) | |
| |
|
Rupintrivir (AG-7088, Rupinavir) is a peptidomimetic antiviral drug which acts as a 3C and 3CL protease inhibitor. It was developed for the treatment of rhinoviruses, and has subsequently been investigated for the treatment of other viral diseases including those caused by picornaviruses,norovirus, and coronaviruses, such as SARS and COVID-19.